This is really bad. It is such a blatant decision that says Merck did not do the right thing about protecting patients, |
This is really bad. It is such a blatant decision that says Merck did not do the right thing about protecting patients. |
We believe that parents are very sensitive to safety issues for ADHD drugs and that a new warning could further add to pressure on the product. |
We believe this decision is only worth $1 to $2 in upside to Merck, as this case was known to be relatively weak, |
What Merck has going for them in this case is that the plaintiffs are still alive. Beyond that, these are the more relevant cases to the plaintiffs because the patients allegedly have taken the drug for more than the 18-month interval. It makes the case more compelling. |